Oakland, CA, United States of America

David Ag Deacon

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Ag Deacon: Innovator in Substance Abuse Treatment

Introduction

David Ag Deacon is an accomplished inventor based in Oakland, CA. He has made significant contributions to the field of substance abuse treatment through his innovative approaches. His work focuses on improving medication adherence among patients struggling with substance abuse issues.

Latest Patents

David Ag Deacon holds a patent for "Systems and methods for treatment adherence in substance abuse treatment." This patent addresses a critical challenge faced by patients who are prescribed medication that diminishes the positive effects of substances. Many patients do not consistently take their medication due to the desire to experience the high from the substance. To combat this issue, Deacon's invention incorporates systems and methods that provide medication reminders and other actions in close temporal proximity to distract patients from their cravings.

Career Highlights

Deacon's career is marked by his dedication to developing solutions that enhance the effectiveness of substance abuse treatment. His innovative mindset has led to the creation of a patent that is poised to make a meaningful impact in the lives of many individuals struggling with addiction.

Collaborations

Throughout his career, David has collaborated with notable professionals in the field, including Robert P. Nix and John E. Mendelson. These partnerships have allowed him to refine his ideas and contribute to the advancement of treatment methodologies.

Conclusion

David Ag Deacon's work exemplifies the importance of innovation in addressing complex health challenges. His patent for treatment adherence systems represents a significant step forward in supporting patients with substance abuse problems. Through his efforts, Deacon is helping to pave the way for more effective treatment solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…